AE.1 |
Structure/Physicochemical Properties |
AE.9 |
Formation of Common (Identical) Compounds |
AE.2 |
Common Biological Targets with Common Metabolites |
AE.10 |
Exposure of Biological Targets to Common Compounds |
AE.3 |
Common Biological Targets without Common Metabolites (Qualitative) |
AE.11 |
Extent of the Bioavailability of the Parent Compound |
AE.4 |
Common Biological Targets without Common Metabolites (Quantitative) |
AE.12 |
Formation and Impact of Non-common Compounds/Exposure to Other Compounds than those Linked to the Prediction |
AE.5 |
Environmental Degradation to Non-common Compounds |
AE.13 |
Metabolites of Source and Target have been Identified |
AE.6 |
Environmental Bioaccumulation of Potential Non-common Compounds |
AE.14 |
Potential Presence of Uncharacterized Metabolites or Impurities |
AE.7 |
Common Environmental Degradation Pathways |
Other Assessment Elements
|
AE.8 |
Toxicodynamic Similarity based on the Data from a Bridging (OECD Test Guideline) Study |
AE.15 |
Characterization of Constituents (for Multi-Constituent or UVCB Substances) |
|
|
AE.16 |
Toxicodynamic Similarity based on the Data from a Bridging (Not a Guideline) Study |
|
|
AE.17 |
Lack of Observed Adverse Effects |